{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T19:59:28Z","timestamp":1790711968384,"version":"4.1.0"},"reference-count":64,"publisher":"MDPI AG","issue":"1","license":[{"start":{"date-parts":[[2017,1,7]],"date-time":"2017-01-07T00:00:00Z","timestamp":1483747200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Toxins"],"abstract":"<jats:p>Patients with chronic kidney disease (CKD) have an increased risk of vascular disease, which is associated with considerable health care costs. Vascular disease in CKD differs clinically and pathobiologically from that in patients with normal renal function. Besides the traditional risk factors, retention of uremic toxins contributes to the pathogenesis of vascular disease in patients with CKD. Indoxyl sulfate is a protein-bound uremic toxin and is inefficiently removed by conventional dialysis. Accumulating evidence suggests that indoxyl sulfate is a vascular toxin involved in atherosclerosis, arteriosclerosis, vascular calcification and vascular repair. Clinically, indoxyl sulfate is associated with total and cardiovascular mortality in patients with CKD. Recent studies have indicated that in addition to coronary and cerebral arteries, indoxyl sulfate plays a role in peripheral artery disease (PAD) and dialysis graft thrombosis. Emerging evidence suggests that indoxyl sulfate is implicated via novel mechanisms, including progenitor cell-related neovascularization and tissue factor-related hypercoagulability. These findings raise the possibility that strategies targeting serum indoxyl sulfate may have the potential to improve the outcomes of PAD and dialysis vascular access in patients with CKD.<\/jats:p>","DOI":"10.3390\/toxins9010025","type":"journal-article","created":{"date-parts":[[2017,1,9]],"date-time":"2017-01-09T11:03:23Z","timestamp":1483959803000},"page":"25","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":17,"title":["Impact of Indoxyl Sulfate on Progenitor Cell-Related Neovascularization of Peripheral Arterial Disease and Post-Angioplasty Thrombosis of Dialysis Vascular Access"],"prefix":"10.3390","volume":"9","author":[{"given":"Chih-Cheng","family":"Wu","sequence":"first","affiliation":[{"name":"Cardiovascular Center, National Taiwan University Hospital, Hsinchu Branch, Hsinchu 30059, Taiwan"},{"name":"National Tsing-Hua University, Institute of Biomedical Engineering, Hsinchu 30013, Taiwan"},{"name":"School of Medicine, National Yang-Ming University, Taipei 11217, Taiwan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Szu-Chun","family":"Hung","sequence":"additional","affiliation":[{"name":"Division of Nephrology, Taipei Tzu Chi Hospital, Buddhist Tzu Chi Medical Foundation and School of Medicine, Tzu Chi University, Hualien 97004, Taiwan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7477-0388","authenticated-orcid":false,"given":"Ko-Lin","family":"Kuo","sequence":"additional","affiliation":[{"name":"Division of Nephrology, Taipei Tzu Chi Hospital, Buddhist Tzu Chi Medical Foundation and School of Medicine, Tzu Chi University, Hualien 97004, Taiwan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9017-2081","authenticated-orcid":false,"given":"Der-Cherng","family":"Tarng","sequence":"additional","affiliation":[{"name":"Institutes of Physiology and Clinical Medicine, National Yang-Ming University, Taipei 11217, Taiwan"},{"name":"Division of Nephrology, Department of Medicine, Taipei Veterans General Hospital, Taipei 11217, Taiwan"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2017,1,7]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"1046","DOI":"10.1160\/TH11-06-0422","article-title":"Venous and arterial thrombosis in dialysis patients","volume":"106","author":"Ocak","year":"2011","journal-title":"Thromb. Haemost."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1046\/j.1525-139X.2003.16048.x","article-title":"Thrombosis in end-stage renal disease","volume":"16","author":"Casserly","year":"2003","journal-title":"Semin. Dial."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"2484","DOI":"10.1111\/j.1538-7836.2012.04921.x","article-title":"Mortality due to pulmonary embolism, myocardial infarction, and stroke among incident dialysis patients","volume":"10","author":"Ocak","year":"2012","journal-title":"J. Thromb. Haemost."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"2477","DOI":"10.1161\/STROKEAHA.115.009095","article-title":"Risk factors of ischemic stroke and subsequent outcome in patients receiving hemodialysis","volume":"46","author":"Findlay","year":"2015","journal-title":"Stroke"},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"1799","DOI":"10.1046\/j.1523-1755.2002.00638.x","article-title":"Incident acute coronary syndromes in chronic dialysis patients in the united states1","volume":"62","author":"Trespalacios","year":"2002","journal-title":"Kidney Int."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"1914","DOI":"10.1161\/CIRCULATIONAHA.105.607390","article-title":"Peripheral arterial disease in patients with end-stage renal disease: Observations from the Dialysis Outcomes and Practice Patterns Study (DOPPS)","volume":"114","author":"Rajagopalan","year":"2006","journal-title":"Circulation"},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"641","DOI":"10.1053\/j.ajkd.2012.02.340","article-title":"Peripheral artery disease and CKD: A focus on peripheral artery disease as a critical component of CKD care","volume":"60","author":"Garimella","year":"2012","journal-title":"Am. J. Kidney Dis."},{"key":"ref_8","unstructured":"Bethesda, M. (2010). US Renal Data System, Usrds 2010 Annual Data Report: Atlas of Chronic Kidney Disease and End-Stage Rena Disease in the United States."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"917","DOI":"10.1016\/j.jvir.2014.02.010","article-title":"Predictors of patency after balloon angioplasty in hemodialysis fistulas: A systematic review","volume":"25","author":"Neuen","year":"2014","journal-title":"J. Vasc. Interv. Radiol."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"3525","DOI":"10.1093\/ndt\/gfl470","article-title":"Peripheral arterial disease in patients with stages IV and V chronic renal failure","volume":"21","author":"Guerrero","year":"2006","journal-title":"Nephrol. Dial. Transplant."},{"key":"ref_11","first-page":"S150","article-title":"National kidney foundation-dialysis outcomes quality initiative. NKF-DOQI clinical practice guidelines for vascular access","volume":"30","author":"Schwab","year":"1997","journal-title":"Am. J. Kidney Dis."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"1419","DOI":"10.1016\/j.jvir.2014.05.020","article-title":"Factors associated with patency following angioplasty of hemodialysis fistulae","volume":"25","author":"Neuen","year":"2014","journal-title":"J. Vasc. Interv. Radiol."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"945","DOI":"10.1016\/S0272-6386(05)80010-1","article-title":"Predictors of arteriovenous graft patency after radiologic intervention in hemodialysis patients","volume":"37","author":"Lilly","year":"2001","journal-title":"Am. J. Kidney Dis."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"1551","DOI":"10.2215\/CJN.03980609","article-title":"Serum indoxyl sulfate is associated with vascular disease and mortality in chronic kidney disease patients","volume":"4","author":"Barreto","year":"2009","journal-title":"Clin. J. Am. Soc. Nephrol."},{"key":"ref_15","doi-asserted-by":"crossref","unstructured":"Lin, C.-J., Wu, V., Wu, P.-C., and Wu, C.-J. (2015). Meta-analysis of the associations of p-cresyl sulfate (PCS) and indoxyl sulfate (IS) with cardiovascular events and all-cause mortality in patients with chronic renal failure. PLoS ONE, 10.","DOI":"10.1371\/journal.pone.0132589"},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1159\/000098542","article-title":"Indoxyl sulfate and atherosclerotic risk factors in hemodialysis patients","volume":"27","author":"Taki","year":"2007","journal-title":"Am. J. Nephrol."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"30","DOI":"10.2215\/CJN.05340610","article-title":"Indoxyl sulfate\u2013induced endothelial dysfunction in patients with chronic kidney disease via an induction of oxidative stress","volume":"6","author":"Yu","year":"2011","journal-title":"Clin. J. Am. Soc. Nephrol."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1016\/j.atherosclerosis.2012.07.012","article-title":"The role of protein-bound uremic toxins on peripheral artery disease and vascular access failure in patients on hemodialysis","volume":"225","author":"Lin","year":"2012","journal-title":"Atherosclerosis"},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"1576","DOI":"10.1111\/j.1538-7836.2009.03540.x","article-title":"Levels of circulating endothelial progenitor cells are related to uremic toxins and vascular injury in hemodialysis patients","volume":"7","author":"Dou","year":"2009","journal-title":"J. Thromb. Haemost."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1159\/000299798","article-title":"Indoxyl sulfate upregulates expression of ICAM-1 and MCP-1 by oxidative stress-induced NF-kappa\u03b2 activation","volume":"31","author":"Tumur","year":"2010","journal-title":"Am. J. Nephrol."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"2051","DOI":"10.1093\/ndt\/gfn757","article-title":"Indoxyl sulphate induces oxidative stress and the expression of osteoblast-specific proteins in vascular smooth muscle cells","volume":"24","author":"Muteliefu","year":"2009","journal-title":"Nephrol. Dial. Transplant."},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"1892","DOI":"10.1093\/ndt\/gfm861","article-title":"Indoxyl sulphate promotes aortic calcification with expression of osteoblast-specific proteins in hypertensive rats","volume":"23","author":"Adijiang","year":"2008","journal-title":"Nephrol. Dial. Transplant."},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1053\/j.jrn.2008.10.014","article-title":"Indoxyl sulfate promotes proliferation of human aortic smooth muscle cells by inducing oxidative stress","volume":"19","author":"Muteliefu","year":"2009","journal-title":"J. Ren. Nutr."},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"1780","DOI":"10.1038\/sj.ki.5000340","article-title":"Indoxyl sulfate stimulates proliferation of rat vascular smooth muscle cells","volume":"69","author":"Yamamoto","year":"2006","journal-title":"Kidney Int."},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"442","DOI":"10.1111\/j.1523-1755.2004.00399.x","article-title":"The uremic solutes p-cresol and indoxyl sulfate inhibit endothelial proliferation and wound repair","volume":"65","author":"Dou","year":"2004","journal-title":"Kidney Int."},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"1302","DOI":"10.1111\/j.1538-7836.2007.02540.x","article-title":"The uremic solute indoxyl sulfate induces oxidative stress in endothelial cells","volume":"5","author":"Dou","year":"2007","journal-title":"J. Thromb. Haemost."},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"1841","DOI":"10.1007\/s00216-012-5929-3","article-title":"Protein-bound uremic toxins in hemodialysis patients measured by liquid chromatography\/tandem mass spectrometry and their effects on endothelial ROS production","volume":"403","author":"Itoh","year":"2012","journal-title":"Anal. Bioanal. Chem."},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"566","DOI":"10.1111\/j.1538-7836.2005.01780.x","article-title":"Elevation of circulating endothelial microparticles in patients with chronic renal failure","volume":"4","author":"Faure","year":"2006","journal-title":"J. Thromb. Haemost."},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"733","DOI":"10.1038\/ki.2013.133","article-title":"Indolic uremic solutes increase tissue factor production in endothelial cells by the aryl hydrocarbon receptor pathway","volume":"84","author":"Gondouin","year":"2013","journal-title":"Kidney Int."},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"758","DOI":"10.1016\/j.bbrc.2011.05.084","article-title":"Nitric oxide counters the inhibitory effects of uremic toxin indoxyl sulfate on endothelial cells by governing ERK MAP kinase and myosin light chain activation","volume":"409","author":"Kharait","year":"2011","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1111\/j.1744-9987.2010.00885.x","article-title":"Uremic toxin indoxyl sulfate inhibits human vascular smooth muscle cell proliferation","volume":"15","author":"Mozar","year":"2011","journal-title":"Ther. Apher. Dial."},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1161\/CIRCULATIONAHA.112.118174","article-title":"Uremic serum and solutes increase post\u2013vascular interventional thrombotic risk through altered stability of smooth muscle cell tissue factor","volume":"127","author":"Chitalia","year":"2013","journal-title":"Circulation"},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"38869","DOI":"10.1074\/jbc.M110.166686","article-title":"Indoxyl sulfate induces leukocyte-endothelial interactions through up-regulation of E-selectin","volume":"285","author":"Ito","year":"2010","journal-title":"J. Biol. Chem."},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"1981","DOI":"10.1681\/ASN.2012030281","article-title":"Protein-bound uremic toxins stimulate crosstalk between leukocytes and vessel wall","volume":"24","author":"Pletinck","year":"2013","journal-title":"J. Am. Soc. Nephrol."},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"1771","DOI":"10.1093\/eurheartj\/ehp574","article-title":"Does indoxyl sulfate, a uraemic toxin, have direct effects on cardiac fibroblasts and myocytes?","volume":"31","author":"Lekawanvijit","year":"2010","journal-title":"Eur. Heart J."},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"609","DOI":"10.1007\/s10456-013-9339-8","article-title":"In acute kidney injury, indoxyl sulfate impairs human endothelial progenitor cells: Modulation by statin","volume":"16","author":"Wu","year":"2013","journal-title":"Angiogenesis"},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"574","DOI":"10.1016\/j.kint.2015.11.020","article-title":"Indoxyl sulfate suppresses endothelial progenitor cell-mediated neovascularization","volume":"89","author":"Hung","year":"2016","journal-title":"Kidney Int."},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1159\/000191468","article-title":"Indoxyl sulfate inhibits nitric oxide production and cell viability by inducing oxidative stress in vascular endothelial cells","volume":"29","author":"Tumur","year":"2009","journal-title":"Am. J. Nephrol."},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"1524","DOI":"10.1046\/j.1523-1755.1999.00668.x","article-title":"Nontraumatic lower extremity amputations in the medicare end-stage renal disease population","volume":"56","author":"Eggers","year":"1999","journal-title":"Kidney Int."},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"2013","DOI":"10.1038\/sj.ki.5000448","article-title":"Subtotal nephrectomy impairs ischemia-induced angiogenesis and hindlimb re-perfusion in rats","volume":"69","author":"Jacobi","year":"2006","journal-title":"Kidney Int."},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1038\/35025215","article-title":"Vascular-specific growth factors and blood vessel formation","volume":"407","author":"Yancopoulos","year":"2000","journal-title":"Nature"},{"key":"ref_42","first-page":"36","article-title":"Endothelial progenitor cells for vasculogenesis","volume":"20","author":"Murasawa","year":"2005","journal-title":"Physiology (Bethesda)"},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"641","DOI":"10.1111\/j.1523-1755.2004.00784.x","article-title":"Uremia causes endothelial progenitor cell deficiency","volume":"66","author":"Bahlmann","year":"2004","journal-title":"Kidney Int."},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1681\/ASN.2014121241","article-title":"The aryl hydrocarbon receptor is a critical regulator of tissue factor stability and an antithrombotic target in uremia","volume":"27","author":"Shivanna","year":"2016","journal-title":"J. Am. Soc. Nephrol."},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"934","DOI":"10.3390\/toxins6030934","article-title":"The aryl hydrocarbon receptor-activating effect of uremic toxins from tryptophan metabolism: A new concept to understand cardiovascular complications of chronic kidney disease","volume":"6","author":"Sallee","year":"2014","journal-title":"Toxins (Basel)"},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"2078","DOI":"10.1046\/j.1523-1755.1999.00409.x","article-title":"Vascular access for hemodialysis","volume":"55","author":"Schwab","year":"1999","journal-title":"Kidney Int."},{"key":"ref_47","doi-asserted-by":"crossref","first-page":"128","DOI":"10.7326\/0003-4819-138-2-200301210-00014","article-title":"Congenital thrombophilic states associated with venous thrombosis: A qualitative overview and proposed classification system","volume":"138","author":"Crowther","year":"2003","journal-title":"Ann. Intern. Med."},{"key":"ref_48","doi-asserted-by":"crossref","first-page":"1526","DOI":"10.1681\/ASN.2010101119","article-title":"Intradialytic hypotension and vascular access thrombosis","volume":"22","author":"Chang","year":"2011","journal-title":"J. Am. Soc. Nephrol."},{"key":"ref_49","first-page":"393","article-title":"Hereditary and acquired thrombophilic disorders complicating vascular access in haemodialysisl","volume":"3","author":"Sarkar","year":"2010","journal-title":"NDT Plus"},{"key":"ref_50","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1159\/000045504","article-title":"Hypercoagulopathy in a hemodialysis patient: Are elevations in factors VII and VIII effective?","volume":"83","author":"Baskin","year":"1999","journal-title":"Nephron"},{"key":"ref_51","doi-asserted-by":"crossref","first-page":"1255","DOI":"10.1681\/ASN.V1261255","article-title":"Circulating levels of plasminogen activator inhibitor type-1, tissue plasminogen activator, and thrombomodulin in hemodialysis patients: Biochemical correlations and role as independent predictors of coronary artery stenosis","volume":"12","author":"Segarra","year":"2001","journal-title":"J. Am. Soc. Nephrol."},{"key":"ref_52","doi-asserted-by":"crossref","first-page":"480","DOI":"10.1160\/TH03-04-0243","article-title":"Thrombin activatable fibrinolysis inhibitor (TAFI) and markers of endothelial cell injury in dialyzed patients with diabetic nephropathy","volume":"91","author":"Malyszko","year":"2004","journal-title":"Thromb. Haemost."},{"key":"ref_53","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1038\/sj.thj.6200072","article-title":"Tissue factor coagulation pathway and blood cells activation state in renal insufficiency","volume":"2","author":"Mercier","year":"2001","journal-title":"Hematol. J."},{"key":"ref_54","doi-asserted-by":"crossref","first-page":"1108","DOI":"10.1681\/ASN.2004110999","article-title":"Thrombophilia and the risk for hemodialysis vascular access thrombosis","volume":"16","author":"Knoll","year":"2005","journal-title":"J. Am. Soc. Nephrol."},{"key":"ref_55","doi-asserted-by":"crossref","first-page":"962","DOI":"10.2215\/CJN.03860412","article-title":"Thrombophilia and arteriovenous fistula survival in ESRD","volume":"8","author":"Salmela","year":"2013","journal-title":"Clin. J. Am. Soc. Nephrol."},{"key":"ref_56","doi-asserted-by":"crossref","first-page":"797","DOI":"10.1016\/S0272-6386(03)00860-6","article-title":"Hypercoagulability, a serious problem in patients with ESRD on maintenance hemodialysis, and its correction after kidney transplantation","volume":"42","author":"Nampoory","year":"2003","journal-title":"Am. J. Kidney Dis."},{"key":"ref_57","doi-asserted-by":"crossref","first-page":"1254","DOI":"10.1681\/ASN.2015010068","article-title":"Serum indoxyl sulfate associates with postangioplasty thrombosis of dialysis grafts","volume":"27","author":"Wu","year":"2016","journal-title":"J. Am. Soc. Nephrol."},{"key":"ref_58","first-page":"S211","article-title":"Indoxyl sulfate stimulates renal synthesis of transforming growth factor-beta 1 and progression of renal failure","volume":"63","author":"Miyazaki","year":"1997","journal-title":"Kidney Int. Suppl."},{"key":"ref_59","doi-asserted-by":"crossref","unstructured":"Yisireyili, M., Saito, S., Abudureyimu, S., Adelibieke, Y., Ng, H.-Y., Nishijima, F., Takeshita, K., Murohara, T., and Niwa, T. (2014). Indoxyl sulfate-induced activation of (pro)renin receptor promotes cell proliferation and tissue factor expression in vascular smooth muscle cells. PLoS ONE, 9.","DOI":"10.1371\/journal.pone.0109268"},{"key":"ref_60","doi-asserted-by":"crossref","first-page":"C126","DOI":"10.1152\/ajpcell.00329.2011","article-title":"Indoxyl sulfate promotes vascular smooth muscle cell senescence with upregulation of p53, p21, and prelamin a through oxidative stress","volume":"303","author":"Muteliefu","year":"2012","journal-title":"Am. J. Physiol. Cell Physiol."},{"key":"ref_61","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1038\/nm0402-403","article-title":"Hematopoietic stem cells differentiate into vascular cells that participate in the pathogenesis of atherosclerosis","volume":"8","author":"Sata","year":"2002","journal-title":"Nat. Med."},{"key":"ref_62","doi-asserted-by":"crossref","unstructured":"Wu, C.C., Huang, P.H., Lai, C.L., Leu, H.B., Chen, J.W., and Lin, S.J. (2014). The impact of endothelial progenitor cells on restenosis after percutaneous angioplasty of hemodialysis vascular access. PLoS ONE, 9.","DOI":"10.1371\/journal.pone.0101058"},{"key":"ref_63","doi-asserted-by":"crossref","first-page":"2625","DOI":"10.1093\/eurheartj\/ehq184","article-title":"Circulating endothelial progenitor cell levels and function in patients who experienced late coronary stent thrombosis","volume":"31","author":"Lev","year":"2010","journal-title":"Eur. Heart J."},{"key":"ref_64","doi-asserted-by":"crossref","first-page":"428","DOI":"10.1159\/000452428","article-title":"Circulating progenitor cells affect thrombosis of dialysis arteriovenous fistulas","volume":"44","author":"Chen","year":"2016","journal-title":"Am. J. Nephrol."}],"container-title":["Toxins"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2072-6651\/9\/1\/25\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T18:25:42Z","timestamp":1760207142000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2072-6651\/9\/1\/25"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,1,7]]},"references-count":64,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2017,1]]}},"alternative-id":["toxins9010025"],"URL":"https:\/\/doi.org\/10.3390\/toxins9010025","relation":{},"ISSN":["2072-6651"],"issn-type":[{"value":"2072-6651","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,1,7]]}}}